Surgical approach to the patient with familial hyperparathyroidism

Current Treatment Options in Oncology

Volumn 7, Issue 4, 2006, Pages 326-333

  VanderWalde, Lindi H ^b   Haigh, Philip I ^a  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE;

ADENOMA; AUTOTRANSPLANTATION; CLINICAL TRIAL; HUMAN; HYPERPARATHYROIDISM; HYPOCALCEMIA; HYPOPARATHYROIDISM; JAW TUMOR; MULTIPLE ENDOCRINE NEOPLASIA; NERVE INJURY; PARATHYROID CARCINOMA; PARATHYROID GLAND; PARATHYROIDECTOMY; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIMARY HYPERPARATHYROIDISM; RECURRENT LARYNGEAL NERVE; REVIEW; RISK ASSESSMENT; SIPPLE SYNDROME; SURGICAL APPROACH; SURGICAL TECHNIQUE; THYMECTOMY;

HUMANS; HYPERPARATHYROIDISM; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PARATHYROIDECTOMY;

EID: 33745884079     PISSN: 15272729     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11864-006-0042-5     Document Type: Review

References (32)

1. Kouvaraki MA, Lee JE, Shapiro SE, et al.: Genotype-phenotype analysis in multiple endocrine neoplasia type 1. Arch Surg 2002, 137:641-647.
2. Langer P, Wild A, Hall A, et al.: Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours. Br J Surg 2003, 90:1599-1603.
3. Doherty GM, Lairmore TC, DeBenedetti MK: Multiple endocrine neoplasia type 1 parathyroid adenoma development over time. World J Surg 2004, 28:1139-1142.
4. Brandi ML, Gagel RF, Angeli A, et al.: Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001, 86:5658-5671.
5. Goudet P, Cougard P, Verges B, et al.: Hyperparathyroidism n multiple endocrine neoplasia type I: surgical trends and results of a 256-patient series from Groupe d'Etude des Néoplasies Endocriniennes Multiples Study Group. World J Surg 2001, 25:886-890.
6. Arnalsteen LC, Alesina PF, Quiereux JL, et al.: Long-term results of less than total parathyroidectomy for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery 2002, 132:1119-1125.
7. Dotzenrath C, Cupisti K, Goretzki PE, et al.: Long-term biochemical results after operative treatment of primary hyperparathyroidism associated with multiple endocrine neoplasia type I and IIa: is a more or less extended operation essential? Eur J Surg 2001, 167:173-178.
8. Lee CH, Tseng LM, Chen JY, et al.: Primary hyperparathyroidism in multiple endocrine neoplasia type 1: individualized management with low recurrence rates. Ann Surg Oncol 2006, 13:103-109.
9. Elaraj DM, Skarulis MC, Libutti SK, et al.: Results of initial operation for hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Surgery 2003, 134:858-865.
10. Lambert LA, Shapiro SE, Lee JE, et al.: Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Arch Surg 2005, 140:374-382.
11. Kivlen MH, Bartlett DL, Libutti SK, et al.: Reoperation for hyperparathyroidism in multiple endocrine neoplasia type 1. Surgery 2001, 130:991-998.
12. Sierra M, Gibelin H, Kraimps JL: Familial hyperparathyroidism in multiple endocrine neoplasia syndromes. In Textbook of Endocrine Surgery, edn 2. Edited by Clark OH, Dub QY, Kebebew E. Philadelphia: Elsevier; 2005:493-501.
13. Gibril F, Chen YJ, Schrump DS, et al.: Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Enocrinol Metab 2003, 88:1066-1081.
14. Teh BT, Zedenius J, Kytola S, et al.: Thymic carcinoids in multiple endocrine neoplasia type 1. Ann Surg 1998, 228:99-105.
15. Ferolla P, Falchetti A, Filosso P, et al.: Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series. J Clin Endocrinol Metab 2005, 90:2603-2609.
16. Burgess JR, Giles N, Shepherd JJ: Malignant thymic carcinoid is not prevented by transcervical thymectomy in multiple endocrine neoplasia type 1. Clin Endocrinol 2001, 55:689-693.
17. Kraimps JL, Denizot A, Carnaille B, et al.: Primary hyperparathyroidism in multiple endocrine neoplasia type Iia: retrospective French multicentric study. World J Surg 1996, 20:808-813.
18. Raue F, Kraimps JL, Dralle H, et al.: Primary hyperparathyroidism in multiple endocrine neoplasia type 2A. J Int Med 1995, 238:369-371.
19. Herfarth KK, Bartsch F, Doherty GM, et al.: Surgical management of hyperparathyroidism in patients with multiple endocrine neoplasia type 2A. Surgery 1996, 120:966-974.
20. Decker RA, Geiger JD, Cox CE, et al.: Prophylactic surgery for multiple endocrine neoplasia type Iia after genetic diagnosis: is parathyroid transplantation indicated? World J Surg 1996, 20:814-821.
21. Warner J, Epstein M, Sweet A, et al.: Genetic testing in familial isolated hyperparathyroidism: unexpected results and their implications. J Med Genet 2004, 41:155-160.
22. Pannett AAJ, Kennedy AM, Turner JJO, et al.: Multiple endocrine neoplasia type 1 (MEN1) germline mutations in familial isolated primary hyperparathyroidism. Clin Endocrinol 2003, 58:639-646.
23. Haven CJ, Wong FK, van Dam LW, et al.: A genotypic and histopathological study of a large Dutch kindred with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 2000, 85:1449-1454.
24. Cavaco BM, Barros L, Pannett AA, et al.: The hyperparathyroidism-jaw tumour syndrome in a Portuguese kindred. Q J Med 2001, 94:213-222.
25. Huang SM: Familial hyperparathyroidism. In Textbook of Endocrine Surgery, edn 2. Edited by Clark OH, Duh QY, Kebebew E. Philadelphia: Elsevier; 2005:493-501.
26. Szabo E, Hellman P, Lundgren E, et al.: Parathyroidectomy in familial hypercalcemia with clinical characteristics of primary hyperparathyroidism and familial hypocalciuria hypercalcemia. Surgery 2002, 131:257-263.
27. Khan AA, Bilezikian JP, Kung AW, et al.: Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trail. J Clin Endocrinol Metab 2004, 89:3319-3325.
28. Chow CC, Chan WB, Li JK, et al.: Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism. J Clin Endocrinol Metab 2003, 88:581-587.
29. Parker CR, Blackwell PJ, Fairbairn KJ, Hosking DJ: Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study. J Clin Endocrinol Metab 2002, 87:4482-4489.
30. Horiuchi T, Onouchi T, Inoue J, et al.: A strategy for the management of elderly women with primary hyperparathyroidism: a comparison of etidronate therapy with parathyroidectomy. Gerontology 2002, 48:103-108.
31. Carniero DM, Irvin GL, Inabnet WB: Limited versus radical parathyroidectomy in familial isolated primary hyperparathyroidism. Surgery 2002, 132:1050-1055.
32. Tonelli F, Spini S, Tommasi M, et al.: Intraoperative parathormone measurements in patients with multiple endocrine neoplasia type 1 syndrome and hyperparathyroidism. World J Surg 2000, 24:556-563.